We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


12 July 2021 By Dasha Afanasieva

A raft of companies like livestock firm Huvepharma and BASF had to cancel European listings. Trendier players Soho House, Turkish retailer Hepsiburada and Italian vaccine vial maker Stevanato have opted for New York. Lacklustre IPO trading makes it hard to coax back investors.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)